Protective immunity against avian influenza induced by a fowlpox virus recombinant
- PMID: 2854339
- DOI: 10.1016/0264-410x(88)90101-6
Protective immunity against avian influenza induced by a fowlpox virus recombinant
Abstract
Fowlpox virus, the prototypic virus of the genus Avipoxvirus has a natural host range limited to avian species. As such, fowlpox virus provides a suitable candidate for the development of a species-specific recombinant viral vector. This paper reports the development of a fowlpox virus recombinant expressing the haemagglutinin molecule from a highly virulent avian influenza virus. On immunization of chickens and turkeys with the recombinant, protection is afforded against a lethal challenge with either the homologous or a heterologous influenza virus strain.
Similar articles
-
Vaccinating chickens against avian influenza with fowlpox recombinants expressing the H7 haemagglutinin.Aust Vet J. 2000 Jan;78(1):44-8. doi: 10.1111/j.1751-0813.2000.tb10359.x. Aust Vet J. 2000. PMID: 10736685
-
Recombinant fowlpox virus inducing protective immunity in non-avian species.Vaccine. 1988 Dec;6(6):497-503. doi: 10.1016/0264-410x(88)90100-4. Vaccine. 1988. PMID: 2854338
-
Protection of chickens against highly lethal H5N1 and H7N1 avian influenza viruses with a recombinant fowlpox virus co-expressing H5 haemagglutinin and N1 neuraminidase genes.Avian Pathol. 2003 Feb;32(1):25-32. doi: 10.1080/0307945021000070688. Avian Pathol. 2003. PMID: 12745375 Clinical Trial.
-
Recombinant fowlpox virus vaccines for poultry.Immunol Cell Biol. 1993 Oct;71 ( Pt 5)(5):391-7. doi: 10.1038/icb.1993.45. Immunol Cell Biol. 1993. PMID: 8270268 Free PMC article. Review.
-
Fowlpox virus as a recombinant vaccine vector for use in mammals and poultry.Expert Rev Vaccines. 2005 Feb;4(1):63-76. doi: 10.1586/14760584.4.1.63. Expert Rev Vaccines. 2005. PMID: 15757474 Review.
Cited by
-
Development of a Multi-Antigenic SARS-CoV-2 Vaccine Using a Synthetic Poxvirus Platform.Res Sq [Preprint]. 2020 Jul 17:rs.3.rs-40198. doi: 10.21203/rs.3.rs-40198/v1. Res Sq. 2020. Update in: Nat Commun. 2020 Nov 30;11(1):6121. doi: 10.1038/s41467-020-19819-1. PMID: 32702732 Free PMC article. Updated. Preprint.
-
Cloning and expression of foreign genes in vaccinia virus, using a host range selection system.J Virol. 1989 Sep;63(9):3829-36. doi: 10.1128/JVI.63.9.3829-3836.1989. J Virol. 1989. PMID: 2547999 Free PMC article.
-
Enhanced T cell-mediated protection against malaria in human challenges by using the recombinant poxviruses FP9 and modified vaccinia virus Ankara.Proc Natl Acad Sci U S A. 2005 Mar 29;102(13):4836-41. doi: 10.1073/pnas.0406381102. Epub 2005 Mar 21. Proc Natl Acad Sci U S A. 2005. PMID: 15781866 Free PMC article. Clinical Trial.
-
Immunogenicity of fowlpox virus expressing the avian influenza virus H5 gene (TROVAC AIV-H5) in cats.Clin Diagn Lab Immunol. 2005 Nov;12(11):1340-2. doi: 10.1128/CDLI.12.11.1340-1342.2005. Clin Diagn Lab Immunol. 2005. PMID: 16275953 Free PMC article. Clinical Trial.
-
Genetically engineered poxviruses for recombinant gene expression, vaccination, and safety.Proc Natl Acad Sci U S A. 1996 Oct 15;93(21):11341-8. doi: 10.1073/pnas.93.21.11341. Proc Natl Acad Sci U S A. 1996. PMID: 8876137 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials